A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder
Clinical trial NCT07193563 · COMPLETED
Trial details
- NCT number
- NCT07193563
- Sponsor
- Engrail Therapeutics INC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-05
- Primary completion
- 2026-03-19
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.